-
公开(公告)号:AU783908B2
公开(公告)日:2005-12-22
申请号:AU9744201
申请日:2001-12-21
Applicant: SERVIER LAB
Inventor: NANTEUIL GUILLAUME DE , BENOIST ALAIN , PASTOUREAU PHILIPPE , SABATINI MASSIMO , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON
IPC: C07D491/048 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/444 , A61K31/541 , A61P9/10 , A61P19/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D405/14 , C07D417/14 , C07D491/04
Abstract: 5-Sulfonyl-2-(4-pyridinyl)-benzofuran, benzothiophene or indole derivatives (I), containing a hydroxamic acid function, are new. Benzofuran, benzothiophene or indole derivatives of formula (I) and their isomers, N-oxides and acid or base addition salts are new. R1 = H, halo, 1-6C alkyl or 1-6C alkoxy; X = O, S or NR; R = H or 1-6C alkyl; A = N-hydroxy-carboxamido-substituted tetrahydrofuropyridine, thiomorpholine or tetrahydropyranylmethyl group of formula (i)-(iii); Ra = H, halo, 1-6C alkyl or 1-6C alkoxy; Rb, Rc = H or 1-6C alkyl; and n = 0-2. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NZ538032A
公开(公告)日:2005-11-25
申请号:NZ53803205
申请日:2005-02-02
Applicant: SERVIER LAB
Inventor: KOCH MICHEL , TILLEQUIN FRANCOIS , MICHEL SYLVIE , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , PFEIFFER BRUNO , RENARD PIERRE
IPC: C07D491/147 , A61K31/4375 , A61K31/4985 , A61P35/00 , C07B61/00 , C07D491/14 , C07D491/22
Abstract: A compound of formula (I) is disclosed, wherein: B1 and B2, which may be the same or different, represent, independently of one another, carbon or nitrogen, with the proviso that at least one of B1 or B2 represents nitrogen, and X, Y, X1, Y1, R1, R2, R3, R4, and A are as defined in the specification. The compound of formula (I) is suitable for use in the treatment of cancer.
-
公开(公告)号:AR045549A1
公开(公告)日:2005-11-02
申请号:ARP040103129
申请日:2004-09-01
Applicant: SERVIER LAB
Inventor: MONNERET CLAUDE , DAUZONNE DANIEL , HICKMAN JOHN , PIERRE ALAIN , KRAUS-BERTHIER LAURENCE , PFEIFFER BRUNO , RENARD PIERRE
IPC: A61P35/00 , C07D493/04 , A61K31/36 , C07D307/00 , C07D317/00
Abstract: Reivindicación 1: Compuesto de fórmula (1) en la cual: R1 representa un grupo seleccionado entre H, alquilo C1-6 lineal o ramificado, arilo arilalquilo C1-6 en el cual el grupo alquilo es lineal o ramificado, heteroarilo, heteroarilalquilo C1-6 en el cual el grupo alquilo es lineal o ramificado, alquilcarbonilo C1-6 lineal o ramificado, arilcarbonilo, arilalquilcarbonilo C1-6 en el cual el grupo alquilo es lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, ariloxicarbonilo, arilalcoxicarbonilo C1-6 en el cual el grupo alquilo es lineal o ramificado, heterocicloalcoxicarbonilo, alquilsulfonilo C1-6 lineal o ramificado, arilsulfonilo, arilalquilsulfonilo C1-6 en el cual el grupo alquilo es lineal o ramificado, fosfónico, y Si(Ra)2Rb en la cual Ra y Rb, que pueden ser iguales o diferentes, representan cada uno, un grupo seleccionado entre alquilo C1-6 lineal o ramificado y arilo; Y representa un grupo seleccionado entre HN-NH y N-R2 en la cual: R2 representa un grupo seleccionado entre H, alquilo C1-6 lineal o ramificado, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, alquenilo C2-6 lineal o ramificado, alquinilo C2-6 lineal o ramificado y un grupo de fórmula -T1-R5 en la cual: T1 representa un grupo seleccionado entre una cadena alquileno C1-6 lineal o ramificada (opcionalmente sustituida por uno o más grupos seleccionados entre hidroxi y alcoxi C1-6 lineal o ramificado), una cadena alquenileno C2-6 lineal o ramificada, o una cadena alquinileno C2-6 lineal o ramificada; R5 representa un grupo seleccionado entre hidroxi, alcoxi C1-6 lineal o ramificado, alquilcarbonilo C1-6 lineal o ramificado, alquilcarboniloxi c1-6 lineal o ramificado, alcoxicarbonilo C1-6 lineal o ramificado, carboxi, halógeno, trihalmetilo, arilo, heteroarilo, cicloalquilo, heterocicloalquilo, NRcRd en la cual Rc, Rd, que pueden ser iguales o diferentes, representan cada uno, un grupo seleccionado entre H, alquilo C1-6 lineal o ramificado, aminoalquilo C1-6 lineal o ramificado en el cual el grupo amino está opcionalmente sustituido por uno o dos grupos idénticos o diferentes alquilo C1-6 lineal o ramificado, hidroxialquilo C1-6 lineal o ramificado, alcoxi C1-6-alquilo C1-6 lineal o ramificado; o C(O)NR´cR´d en la cual R´c y R´d que son iguales o diferentes, representan cada uno, un grupo seleccionado entre H, alquilo C1-6 lineal o ramificado, aminoalquilo C1-6 en el cual el grupo amino está opcionalmente sustituido por uno o dos grupos idénticos o diferentes alquilo C1-6, hidroxialquilo C1-6 lineal o ramificado, alcoxi C1-6-alquilo C1-6 lineal o ramificado, o R´c y R´d, junto con el átomo de N que los lleva, forman un grupo heterocicloalquilo; R3 representa un grupo seleccionado entre H, alquilo C1-6 lineal o ramificado, cicloalquilo, cicloalquilalquilo C1-6 en el cual el grupo alquilo es lineal o ramificado, arilo o arilalquilo C1-6 en el cual el grupo alquilo es lineal o ramificado; R4 representa un grupo seleccionado entre H y alquilo C1-6 lineal o ramificado, a sus enantiómeros, diastereoisómeros, y también a las sales de adición de los mismos con un ácido o con una base farmacéuticamente aceptables, y se entiende que: arilo significa un grupo seleccionado entre fenilo, bifenilo, naftilo, dihidronaftilo, tetrahidronaftilo, indenilo, indanilo y benzociclobutilo; cada uno de esos grupos contiene opcionalmente uno o más sustituyentes, idénticos o diferentes, seleccionados entre halógeno, hidroxi, alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, ciano, nitro, amino, alquilamino C1-6 lineal o ramificado, dialquilamino C1-6 en el cual el grupo alquilo es lineal o ramificado, carboxi, alcoxicarbonilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, alquilcarboniloxi C1-6 lineal o ramificado, alquilcarbonilo C1-6 lineal o ramificado, y aminocarbonilo en la cual el grupo amino está opcionalmente sustituido por uno o dos grupos idénticos o diferentes, alquilo C1-6 lineal o ramificado; heteroarilo significa un grupo mono- o bicíclico aromático o un grupo bicíclico, en el que uno de los anillos es aromático y el otro ciclo está parcialmente hidrogenado, de 5 a 12 miembros, que contiene en el sistema cíclico de uno a tres heteroátomos, idénticos o diferentes, seleccionados entre O, N, y S, y dicho grupo heteroarilo puede ser opcionalmente sustituido por uno o más grupos idénticos o diferentes, seleccionados entre los sustituyentes definidos anteriormente en el caso del grupo arilo; entre los grupos heteroarilo se puede mencionar, sin que implique limitación alguna, el grupo piridilo, pirrolilo, tienilo, furilo, pirazinilo, isotiazolilo, tiazolilo, oxazolilo, isoxazolilo, pirimidinilo, indolilo, benxofuranilo, benzotienilo, quinolilo, isoquinolilo, benzo[1,4]dioxinilo y 2,3-dihidrobenzo[1,4]dioxinilo; cicloalquilo significa un grupo mono- o bicíclico, que es saturado o insaturado pero sin carácter aromático, y que contiene de 3 a 12 átomos de C, y que está opcionalmente sustituido por uno o varios grupos idénticos o diferentes, seleccionados entre halógeno, alquilo C1-6 lineal o ramificado, trihaloalquilo C1-6 lineal o ramificado, hidroxi, amino, alquilamino C1-6 lineal o ramificado, y dialquilamino c1-6 en el cual el grupo alquilo es lineal o ramificado; entre los grupos cicloalquilo, se pueden mencionar, sin que implique limitación alguna, los grupos ciclopropilo, ciclobutilo, ciclopentilo y ciclohexilo; heterocicloalquilo significa un cicloalquilo tal como se ha definido anteriormente, que contiene en el sistema ciclico, de uno a dos heteroátomos, idénticos o diferentes, seleccionados entre O y N, y dicho heterocicloalquilo está opcionalmente sustituido por uno o más grupos idénticos o diferentes definidos anteriormente en el caso del grupo cicloalquilo; entre los grupos heterocicloalquilo se pueden mencionar, sin que implique limitación alguna, el grupo piperidilo, piperazinilo y morfolilo.
-
公开(公告)号:EA006201B1
公开(公告)日:2005-10-27
申请号:EA200400533
申请日:2002-10-21
Applicant: SERVIER LAB
Inventor: PRUDHOMME MICHELLE , MARMINON CHRISTELLE , MOREAU PASCALE , HICKMAN JOHN , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE , BIZOT-ESPIARD JEAN-GUY
IPC: A61K31/7056 , A61P3/04 , A61P3/10 , A61P25/00 , A61P25/16 , A61P25/28 , A61P35/00 , A61P43/00 , C07H19/23
Abstract: Соединениеформулы (I)вкоторой Rи Rкаждыйпредставляетсобойгруппу, выбраннуюизводорода, алкила, арилалкила, гидрокси, гидроксиалкила, дигидроксиалкила, алкокси, алкоксиалкила, аминогруппыи аминоалкила (необязательнозамещенного),Ra и Rb каждыйпредставляетсобойалкиленовуюцепь,X, ХиХкаждыйпредставляетсобойгруппу, выбраннуюизгидрокси, алкокси, арилокси, арилалкокси, алкила, аминогруппы (необязательнозамещенной), галогена, алкилкарбонилоксии азидо,Хпредставляетсобойметилиденовуюгруппуилигруппуформулы -Rc-X, которыеимеютзначения, указанныев описании,ихизомеры, атакжеихаддитивныесолис фармацевтическиприемлемойкислотойилиоснованием. Лекарственныесредства.
-
公开(公告)号:DE60105746T2
公开(公告)日:2005-10-06
申请号:DE60105746
申请日:2001-12-21
Applicant: SERVIER LAB
Inventor: DE NANTEUIL GUILLAUME , BENOIST ALAIN , PASTOUREAU PHILIPPE , SABATINI MASSIMO , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON
IPC: C07D491/048 , A61K31/4433 , A61K31/444 , A61K31/541 , A61P9/10 , A61P19/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D405/14 , C07D417/14 , C07D491/04
Abstract: 5-Sulfonyl-2-(4-pyridinyl)-benzofuran, benzothiophene or indole derivatives (I), containing a hydroxamic acid function, are new. Benzofuran, benzothiophene or indole derivatives of formula (I) and their isomers, N-oxides and acid or base addition salts are new. R1 = H, halo, 1-6C alkyl or 1-6C alkoxy; X = O, S or NR; R = H or 1-6C alkyl; A = N-hydroxy-carboxamido-substituted tetrahydrofuropyridine, thiomorpholine or tetrahydropyranylmethyl group of formula (i)-(iii); Ra = H, halo, 1-6C alkyl or 1-6C alkoxy; Rb, Rc = H or 1-6C alkyl; and n = 0-2. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:MA27576A1
公开(公告)日:2005-10-03
申请号:MA28377
申请日:2005-07-11
Applicant: SERVIER LAB
Inventor: GALLET SEBASTIEN , BERTHELOT PASCAL , LEBEGUE NICOLAS , FLOUQUET NATHALIE , CARATO PASCAL , HICKMAN JOHN , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE
IPC: A61P35/00 , C07D513/04 , C07D515/04 , A61K31/55
Abstract: NOUVEAUX DERIVES D'AZEPINES TRICYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT Composé de formule (I) : dans laquelle : - représente un groupement benzo ou pyrido, éventuellement fusionné en position 2-3, 3-4, ou 4-5, et éventuellement substitué, - W représente un groupement X„Y ou Y„X avec : X représentant un groupement et Y représentant un atome d'oxygène ou un groupement N-R3, - n représente zéro ou un entier tel que 1 (
-
公开(公告)号:BRPI0500306A
公开(公告)日:2005-09-27
申请号:BRPI0500306
申请日:2005-02-03
Applicant: SERVIER LAB
Inventor: KOCH MICHEL , TILLEQUIN FRANCOIS , MICHEL SYLVIE , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , PFEIFFER BRUNO , RENARD PIERRE
IPC: C07D491/147 , A61K31/4375 , A61K31/4985 , A61P35/00 , C07B61/00 , C07D491/14 , C07D491/22 , C07D491/04 , A61K31/436
Abstract: Benzo[b]chromeno[g]naphthyridone or pyrano[2',3':7,8]quinolino[2,3-b]quinoxalinone derivatives (I) are new. Benzo[b]chromeno[g]naphthyridone or pyrano[2',3':7,8]quinolino[2,3-b]quinoxalinone derivatives of formula (I) and their isomers, N-oxides and salts are new: B 1, B 2C or N, at least one being N; X, Y : H, halo, OH, 1-6C alkoxy, NO 2, CN, 1-6C alkyl, 2-6C alkenyl, 1-6C polyhaloalkyl or NR aR b; R a, R bH, COCF 3, CONH 2 or 1-6C alkyl optionally substituted with NR' aR' b or NR aR b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); R' a, R' bH or 1-6C alkyl, or NR' aR' b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); X 1, Y 1X and Y or are absent when B 1, B 2 is N; R 1H or 1-6C alkyl; R 2H, 1-6C alkyl, OR" a, NR' aR' b, OT aOR" a, NR" aT aNR' aR' b, NR" aCOT aH, OCOT aH, OT aNR' aR' b, NR" aT aOR" a, NR" aT aCOOR" a or NR" aCOT aNR' aR' b; T a1-6C alkylene; R" aH or 1-6C alkyl; R 3, R 4H or 1-6C alkyl or together form a 3- to 6-membered ring; A : CHR 5CHR 6, CH=CR 7, CR 7=CH, COCHR 8 or CHR 8CO; R 5, R 6H, OR c, NR cR d, SR c, W 1C(W 2)U'V', W 1C(W 2)W 3T 1, W 1SO nW 3T 1, W 1SO nT 1 or C(W 2)T 1, or together form OC(Z)O, NHC(Z)O, OC(Z)NH, NHC(Z)NH, O(CH 2) mO, OCOB'COO, NHCOB'COO or OCOB'CONH, or CR 5R 6 is an oxirane or optionally N-substituted aziridine group; R c, R dH, 1-6C alkyl, aryl, aryl(1-6C)alkyl or COR e; R eH, aryl or NR"' aR"' b; R"' a, R"' bH or NR"' aR"' b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); W 1O, S or NR c; W 2O or S; U' : 1-8C alkylene or 2-8C alkenylene, or is a bond when W 2 is not O and V' is not H, aryl or NH 2; V' : H, aryl, OR c, COOR c, COR c, CONR' aR' b, NR cR d, N(R c)COOR' c or N(R c)COR' c; R' c1-6C alkyl, aryl or aryl(1-6C)alkyl; W 3O, S or NR c; T 1H, 1-6C alkyl, 2-6C alkenyl, aryl, aryl(1-6C)alkyl, or 1-6C alkyl or 2-6C alkenyl substituted with OR c or NR' aR' b; n : 1 or 2; Z : O or S; m : 1-4; B' : bond, 1-6C alkylene or 2-6C alkenylene; R 7H, OR" a, W 1C(W 2)U'V', W 1C(W 2)W 3T 1, W 1SO nW 3T 1, W 1SO nT 1 or C(W 2)T 1; and R 8H, 2-7C alkanoyloxy or OR" a. An independent claim is also included for the preparation of (I). [Image] ACTIVITY : Cytostatic. cis-1,2-Acetoxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-7H-benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one had IC50 values of 0.32 mu M against L1210 murine leukemia cells and 0.037 mu M against KB-3-1 human epidermoid carcinoma cells. MECHANISM OF ACTION : Cell cycle blocker.
-
公开(公告)号:DE60205538D1
公开(公告)日:2005-09-22
申请号:DE60205538
申请日:2002-06-12
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , ATASSI GHANEM , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , GUILBAUD NICOLAS , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , A61K31/407
Abstract: Indenoindolone derivatives (I), their isomers and salts with acids and bases are new. Indenoindolone derivatives (I), their isomers and salts with acids and bases are new; R = H, alkyl (optionally substituted by carboxy, alkoxycarbonyl, or NR10R11), or alkenyl; R1-R8 = H, alkyl (optionally substituted by aryl, carboxy or alkoxycarbonyl), OH, acyloxy, NR12R13, carboxy, alkoxy (optionally substituted by aryl or NR14R15), alkenyloxy, or to adjacent groups R1-R8 = 1 or 2C alkylenedioxy; R9 = H, aryl, heteroaryl or alkyl (optionally containing one or more unsaturations and optionally substituted by one or more aryl, heteroaryl, 3-8C cycloalkyl, CN, or NR17R18 groups); X = O or NR16; R10, R11, R14, R15, R17, R18 = alkyl; NR10+R11, NR14+R15, NR17+R18 = nitrogen heterocycle; R12, R13 = H, alkyl, or NR14R15; R16 = H, alkyl, aryl, or aryl alkyl. Where alkyl, alkoxy, acyloxy, alkenyl and alkenyloxy groups have up to 6 C atoms, aryl is defined as phenyl, biphenyl, or naphthyl (optionally substituted by one or more halogen, alkyl, alkenyl, alkoxy, phenoxy, nitro, CN, amino, mono- and di-alkylamino or 1-2C alkylenedioxy groups) and heteroaryl groups may be mono- or bicyclic of 5-12 members with 1-3 heteroatoms (O, N, S) and optionally substituted by halogen, alkyl, OH, alkoxy, polyhaloalkyl, amino, mono- and di-alkylamino groups, and nitrogen heterocycles are monocyclic having 5-7 members including 1-3 heteroatoms, one of which is N and the others may be O, N, or S. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:SI1411057T1
公开(公告)日:2005-08-31
申请号:SI200330032
申请日:2003-10-14
Applicant: SERVIER LAB
Inventor: PRUDHOMME MICHELLE , HUGON BERNADETTE , ANIZON FABRICE , HICKMAN JOHN , PIERRE ALAIN , GOLSTEYN ROY , RENARD PIERRE , PFEIFFER BRUNO
IPC: A61K31/40 , A61K31/407 , A61K31/437 , A61K31/7056 , A61K31/706 , A61P35/00 , A61P43/00 , C07D471/22 , C07D487/14 , C07D491/14 , C07D491/147 , C07H19/23
Abstract: (3,4-a:3,4-c) Carbazole derivatives (I), their enantiomers, diastereoisomers and salts with acids and bases. (3,4-a:3,4-c) Carbazole derivatives of formula (I), their enantiomers, diastereoisomers and salts with acids and bases A = ring that is saturated, partially, or fully unsaturated, and that may be aromatic; W' = phenyl or pyridinyl; Z' = U'-V', methylene dioxy or ethylenedioxy; U' = bond, 1-6C alkylene, 2-6C alkenylene, optionally substituted by 1 or 2 halo or OH groups; V' = H, halo, CN, NO2, azido, 1-6C alkyl or alkoxy, aryl, aralkyl, OH, aryloxy, arylalkoxy, formyl, COOH, NH2CO, NR3R4, -C(O)-T1, -C(O)-NR3-T1, NR3C(O)T1, -O-C(O)-T1, -C(O)-OT1, -NR3-T2-NR3R4, -NR3-T2-OR3, -NR3-T2-COOR3, -O-T'2-NR3R4, -O-T'2-OR3, -O-T'2-COOR3, or -S(O)t-R3; R3, R4 = H, 1-6C alkyl, aryl, aralkyl or together form 5-10 membered saturated mono or bicyclic heterocycle, optionally with a second hetero atom (O or N) and optionally substituted by alkyl, aryl, aralkyl, OH, alkoxy, amino mono- or dialkylamino; T1 = alkyl (optionally substituted by -OR3, -NR3R4, -COOR3, -C(O)R3, or -C(O)NR3R4), 2-6C alkenyl, optionally substituted; T2 = 1-6C alkylene; T'2 = 1-6C alkylene optionally substituted by one or more OH groups; t = 0, 1, or 2; Q1 = O or NR2; R2 = H, 1-6C alkyl, aryl, aralkyl, cycloalkyl, cycloalkyl alkyl, -OR3, -NR3R4, -O-T2-NR3R4, NR3-T2-NR3R4, mono- or di-hydroxyalkylamino, -C(O)R3, -NH-C(O)-R3, or 1-6C alkylene optionally substituted by halo, CN, NO2, -OR3, -NR3R4, -COOR3, -C(O)R3, hydroxyalkylamino, dihydroxyalkylamino, -C(O)-NHR3; Q2 = O or NR'2; R'2 = H, 1-6C alkyl, aryl, aralkyl, cycloalkyl, cycloalkyl alkyl, -OR3, -NR3R4, -O-T2-NR3R4, NR3-T2-NR3R4, mono- or di-hydroxyalkylamino, -C(O)R3, -NH-C(O)-R3, or 1-6C alkylene optionally substituted by halo, CN, NO2, -OR3, -NR3R4, -COOR3, -C(O)R3, hydroxyalkylamino, dihydroxyalkylamino, -C(O)-NHR3; X1 = H, OH, alkoxy, mercapto, alkylthio; Y1 = H or X1 and Y1 together form carbonyl or thiocarbonyl; X2 = H, OH, alkoxy, mercapto, alkylthio; Y2 = H or X2 and Y2 together form carbonyl or thiocarbonyl; X'1 = H, OH, alkoxy, mercapto, alkylthio; Y'1 = H or X'1 and Y'1 together form carbonyl or thiocarbonyl; X'2 = H, OH, alkoxy, mercapto, alkylthio; Y'2 = H or X'2 and Y'2 together form carbonyl or thiocarbonyl; R1 = H, 1-6C alkyl (optionally substituted by one or more OH, alkoxy, hydroxyalkoxy, or NR3R4 groups) or it is a group of formula (a); Ra - Rd = a bond, H, halo, OH, alkoxy, aryloxy, arylalkoxy, alkyl, aralkyl, aryl, -NR3R4, azido, -N=NR3, or -O-C(O)-R5; R5 = alkyl optionally substituted by one or more halo, OH, amino, mono- or dialkylamino, aryl, aralkyl, cycloalkyl, or heterocycloalkyl; Re = methylene or -U1-Ra; U1 = a bond or methylene; and n = 0 or 1. with the proviso that the following compounds are not within the scope of (I): 3b, 6a, 6b, 7-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; 5-ethyl-3b, 6a, 6b, 7-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; 3b, 6a, 7, 11c-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; and 3b, 6a, 6b, 7-tetrahydrofuro(3,4a)pyrrolo(3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone.
-
公开(公告)号:ZA200501010B
公开(公告)日:2005-08-30
申请号:ZA200501010
申请日:2005-02-03
Applicant: SERVIER LAB
Inventor: KOCH MICHEL , TILLEQUIN FRANCOIS , MICHEL SYLVIE , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , PFEIFFER BRUNO , RENARD PIERRE
IPC: C07D491/147 , A61K31/4375 , A61K31/4985 , A61P35/00 , C07B61/00 , C07D491/14 , C07D491/22 , C07D , A61K , A61P
Abstract: Benzo[b]chromeno[g]naphthyridone or pyrano[2',3':7,8]quinolino[2,3-b]quinoxalinone derivatives (I) are new. Benzo[b]chromeno[g]naphthyridone or pyrano[2',3':7,8]quinolino[2,3-b]quinoxalinone derivatives of formula (I) and their isomers, N-oxides and salts are new: B 1, B 2C or N, at least one being N; X, Y : H, halo, OH, 1-6C alkoxy, NO 2, CN, 1-6C alkyl, 2-6C alkenyl, 1-6C polyhaloalkyl or NR aR b; R a, R bH, COCF 3, CONH 2 or 1-6C alkyl optionally substituted with NR' aR' b or NR aR b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); R' a, R' bH or 1-6C alkyl, or NR' aR' b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); X 1, Y 1X and Y or are absent when B 1, B 2 is N; R 1H or 1-6C alkyl; R 2H, 1-6C alkyl, OR" a, NR' aR' b, OT aOR" a, NR" aT aNR' aR' b, NR" aCOT aH, OCOT aH, OT aNR' aR' b, NR" aT aOR" a, NR" aT aCOOR" a or NR" aCOT aNR' aR' b; T a1-6C alkylene; R" aH or 1-6C alkyl; R 3, R 4H or 1-6C alkyl or together form a 3- to 6-membered ring; A : CHR 5CHR 6, CH=CR 7, CR 7=CH, COCHR 8 or CHR 8CO; R 5, R 6H, OR c, NR cR d, SR c, W 1C(W 2)U'V', W 1C(W 2)W 3T 1, W 1SO nW 3T 1, W 1SO nT 1 or C(W 2)T 1, or together form OC(Z)O, NHC(Z)O, OC(Z)NH, NHC(Z)NH, O(CH 2) mO, OCOB'COO, NHCOB'COO or OCOB'CONH, or CR 5R 6 is an oxirane or optionally N-substituted aziridine group; R c, R dH, 1-6C alkyl, aryl, aryl(1-6C)alkyl or COR e; R eH, aryl or NR"' aR"' b; R"' a, R"' bH or NR"' aR"' b is a 5- to 7-membered ring optionally containing another heteroatom (O or N); W 1O, S or NR c; W 2O or S; U' : 1-8C alkylene or 2-8C alkenylene, or is a bond when W 2 is not O and V' is not H, aryl or NH 2; V' : H, aryl, OR c, COOR c, COR c, CONR' aR' b, NR cR d, N(R c)COOR' c or N(R c)COR' c; R' c1-6C alkyl, aryl or aryl(1-6C)alkyl; W 3O, S or NR c; T 1H, 1-6C alkyl, 2-6C alkenyl, aryl, aryl(1-6C)alkyl, or 1-6C alkyl or 2-6C alkenyl substituted with OR c or NR' aR' b; n : 1 or 2; Z : O or S; m : 1-4; B' : bond, 1-6C alkylene or 2-6C alkenylene; R 7H, OR" a, W 1C(W 2)U'V', W 1C(W 2)W 3T 1, W 1SO nW 3T 1, W 1SO nT 1 or C(W 2)T 1; and R 8H, 2-7C alkanoyloxy or OR" a. An independent claim is also included for the preparation of (I). [Image] ACTIVITY : Cytostatic. cis-1,2-Acetoxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-7H-benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one had IC50 values of 0.32 mu M against L1210 murine leukemia cells and 0.037 mu M against KB-3-1 human epidermoid carcinoma cells. MECHANISM OF ACTION : Cell cycle blocker.
-
-
-
-
-
-
-
-
-